 He is a co-founder of Annexon Biosciences, Inc., a company making drugs to block neurodegeneration in Alzheimer's and other neurological diseases.He became a member and elected Fellow of the American Association for the Advancement of Science in 2011.In 2013 he was elected to the National Academy of Sciences, becoming the first openly transgender member.